Implications of the German HTA-Process on Market-Uptake of Oral Treatments for Type-2-Diabetes (T2DM) Since 2007

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.496
https://www.valueinhealthjournal.com/article/S1098-3015(17)30830-6/fulltext
Section Title : Disease-Specific Studies
Section Order : 468
First Page : A486
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30830-6&doi=10.1016/j.jval.2017.08.496
HEOR Topics :
Tags :
Regions :